Science Explorer Back to mapMap
Discussion
Company · Tsukuba · Japan

ID Pharma (Japan)

dnavec.co.jp/enROR OpenAlex
World rank, all time
#34,221
of 34,923
Rank in Japan
#1,829
of 1,923
Research works
143
▼ 23% vs 2018-21
Citations
5.8k
40.2 per fractional work
Top-10% rate
11.5%
all institutions 10.0%
vs its own fields
0.91×
1.00× is exactly expected
Open access
39%
world 40%
International
19%
world 18%
ID Pharma (Japan)

Which fields of science does ID Pharma (Japan) work in?

In all years, 57% of research at ID Pharma (Japan) is in Life Sciences, 31% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (41%), Medicine (31%), Immunology and Microbiology (8%). It does 3.5× the world's share of Life Sciences.

Life Sciences: 82 fractional works · 57.3% of its workBiochemistry, Genetics and Molecular Biology: 59 fractional works · 41.1% of its workMolecular Biology: 33 fractional works · 23.0% of its workGenetics: 20 fractional works · 14.1% of its workCell Biology: 2 fractional works · 1.3% of its workBiotechnology: 2 fractional works · 1.3% of its workCancer Research: 1 fractional works · 0.8% of its workBiophysics: 1 fractional works · 0.4% of its workImmunology and Microbiology: 11 fractional works · 7.8% of its workImmunology: 9 fractional works · 6.5% of its workVirology: 2 fractional works · 1.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workAgricultural and Biological Sciences: 6 fractional works · 4.1% of its workAnimal Science and Zoology: 3 fractional works · 1.9% of its workPlant Science: 2 fractional works · 1.6% of its workEcology, Evolution, Behavior and Systematics: 0 fractional works · 0.3% of its workAgronomy and Crop Science: 0 fractional works · 0.2% of its workNeuroscience: 5 fractional works · 3.3% of its workCellular and Molecular Neuroscience: 2 fractional works · 1.6% of its workCognitive Neuroscience: 1 fractional works · 0.7% of its workNeurology: 0 fractional works · 0.3% of its workBehavioral Neuroscience: 0 fractional works · 0.2% of its workEndocrine and Autonomic Systems: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.3% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 0.9% of its workPharmacology: 1 fractional works · 0.9% of its workHealth Sciences: 45 fractional works · 31.5% of its workMedicine: 45 fractional works · 31.1% of its workInfectious Diseases: 9 fractional works · 6.2% of its workEpidemiology: 7 fractional works · 4.7% of its workOncology: 4 fractional works · 3.0% of its workSurgery: 3 fractional works · 2.3% of its workHematology: 3 fractional works · 2.2% of its workPhysiology: 3 fractional works · 2.1% of its workPulmonary and Respiratory Medicine: 2 fractional works · 1.7% of its workPublic Health, Environmental and Occupational Health: 2 fractional works · 1.3% of its workPathology and Forensic Medicine: 1 fractional works · 1.0% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 0.9% of its workGenetics: 1 fractional works · 0.8% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 0.7% of its workOphthalmology: 1 fractional works · 0.6% of its workPharmacology: 1 fractional works · 0.5% of its workReproductive Medicine: 1 fractional works · 0.5% of its workNeurology: 1 fractional works · 0.5% of its workBiochemistry: 0 fractional works · 0.3% of its workHepatology: 0 fractional works · 0.3% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.3% of its workImmunology and Allergy: 0 fractional works · 0.2% of its workSmaller subfields together: 2 fractional works · 1.1% of its workHealth Professions: 0 fractional works · 0.3% of its workNursing: 0 fractional works · 0.1% of its workPhysical Sciences: 15 fractional works · 10.5% of its workEngineering: 6 fractional works · 4.3% of its workElectrical and Electronic Engineering: 3 fractional works · 2.3% of its workBiomedical Engineering: 1 fractional works · 0.9% of its workAutomotive Engineering: 1 fractional works · 0.5% of its workCivil and Structural Engineering: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.3% of its workEnvironmental Science: 3 fractional works · 2.1% of its workHealth, Toxicology and Mutagenesis: 1 fractional works · 1.0% of its workEcology: 1 fractional works · 0.6% of its workEnvironmental Engineering: 1 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.0% of its workComputer Science: 2 fractional works · 1.6% of its workComputer Networks and Communications: 1 fractional works · 0.8% of its workComputational Theory and Mathematics: 0 fractional works · 0.3% of its workComputer Vision and Pattern Recognition: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workChemistry: 2 fractional works · 1.1% of its workOrganic Chemistry: 1 fractional works · 0.5% of its workSpectroscopy: 1 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.0% of its workPhysics and Astronomy: 1 fractional works · 0.5% of its workNuclear and High Energy Physics: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workMaterials Science: 1 fractional works · 0.4% of its workMaterials Chemistry: 1 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.0% of its workChemical Engineering: 0 fractional works · 0.3% of its workBioengineering: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEarth and Planetary Sciences: 0 fractional works · 0.3% of its workAtmospheric Science: 0 fractional works · 0.3% of its workEnergy: 0 fractional works · 0.0% of its workSocial Sciences: 1 fractional works · 0.7% of its workPsychology: 1 fractional works · 0.4% of its workSocial Psychology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workSocial Sciences: 0 fractional works · 0.2% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.1% of its workALL ITS WORKID Pharma (Japan)143fractional works, all years
Life Sciences57%Physical Sciences11%Health Sciences31%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 20 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology5941.1%
    2. Immunology and Microbiology117.8%
    3. Agricultural and Biological Sciences64.1%
    4. Neuroscience53.3%
    5. Pharmacology, Toxicology and Pharmaceutics10.9%
    1. Medicine4531.1%
    2. Health Professions00.3%
    3. Nursing00.1%
    1. Engineering64.3%
    2. Environmental Science32.1%
    3. Computer Science21.6%
    4. Chemistry21.1%
    5. Physics and Astronomy10.5%
    6. Materials Science10.4%
    7. Chemical Engineering00.3%
    8. Earth and Planetary Sciences00.3%
    9. Energy00.0%
    1. Psychology10.4%
    2. Social Sciences00.2%
    3. Economics, Econometrics and Finance00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.19× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 4.10× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 15.78× its world share, 2 worksImmunology and Micro…Neuroscience: 4.28× its world share, 1 worksNeuroscienceChemistry: 0.57× its world share, 0 worksChemistryEnergy: 0.78× its world share, 0 worksEnergyEngineering: 1.33× its world share, 2 worksEngineeringEnvironmental Science: 0.81× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.56× its world share, 0 worksMaterials ScienceHealth Professions: 1.46× its world share, 0 worksHealth ProfessionsMedicine: 0.95× its world share, 2 worksMedicineEconomics, Econometrics and Finance: 0.84× its world share, 0 worksEconomics, Econometr…Psychology: 0.17× its world share, 0 worksPsychologySocial Sciences: 0.18× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 15.8×. Every wedge is a field page.

All 14 fields, with their numbers
  1. Immunology and Microbiology15.78×2 works
  2. Neuroscience4.28×1 works
  3. Biochemistry, Genetics and Molecular Biology4.10×2 works
  4. Health Professions1.46×0 works
  5. Engineering1.33×2 works
  6. Medicine0.95×2 works
  7. Economics, Econometrics and Finance0.84×0 works
  8. Environmental Science0.81×0 works
  9. Energy0.78×0 works
  10. Chemistry0.57×0 works
  11. Materials Science0.56×0 works
  12. Agricultural and Biological Sciences0.19×0 works
  13. Social Sciences0.18×0 works
  14. Psychology0.17×0 works

Who are the top researchers at ID Pharma (Japan)?

Ranked on the quality score, Noemi Fusaki, Mamoru Hasegawa and Akihiro Iida lead among researchers whose main affiliation is ID Pharma (Japan).

  1. 1 Noemi Fusaki Japan · #1,323,954 worldwide 5.7k citations · 52 works
  2. 2 Mamoru Hasegawa Japan · #2,216,515 worldwide 11k citations · 250 works
  3. 3 Akihiro Iida Japan · #2,283,730 worldwide 6.5k citations · 52 works
  4. 4 Toshiaki Tabata Japan · #2,968,978 worldwide 979 citations · 16 works
  5. 5 Hiroshi Ban Japan · #3,039,109 worldwide 2.5k citations · 20 works
  6. 6 Tsugumine Shu Japan · #3,365,950 worldwide 744 citations · 40 works
  7. 7 M Hasegawa Japan · #3,754,579 worldwide 1.9k citations · 64 works
  8. 8 Makoto Inoue Japan · #4,832,422 worldwide 11k citations · 553 works
  9. 9 Yasuji Ueda Japan · #5,894,110 worldwide 1.7k citations · 100 works
All ranked researchers at ID Pharma (Japan)

What are the most cited papers from ID Pharma (Japan)?

The most cited paper from ID Pharma (Japan) is "Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome" (Noemi Fusaki, Hiroshi Ban, Akiyo Nishiyama et al., 2009), with 1,416 citations. Next come "Human iPSC-Based Modeling of Late-Onset Disease via Progerin-Induced Aging" (786) and "Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells" (646).

Most cited papers
#PaperReleasedCitations
1 Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome Noemi Fusaki, Hiroshi Ban, Akiyo Nishiyama et al. · Proceedings of the Japan Academy Series B Open access 2009 1,416
2 Human iPSC-Based Modeling of Late-Onset Disease via Progerin-Induced Aging Justine D. Miller, Yosif M. Ganat, Sarah Kishinevsky et al. · Cell stem cell Open access Dec 2013 786
3 Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells Kosuke Yusa, S. Tamir Rashid, Hélène Strick‐Marchand et al. · Nature Open access 11 Oct 2011 646
4 Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors Hiroshi Ban, Naoki Nishishita, Noemi Fusaki et al. · Proceedings of the National Academy of Sciences Open access 5 Aug 2011 615
5 Generation of Induced Pluripotent Stem Cells from Human Terminally Differentiated Circulating T Cells Tomohisa Seki, Shinsuke Yuasa, Mayumi Oda et al. · Cell stem cell Open access Jul 2010 585
All 60 most cited papers, with filters and sorting

Which keywords describe research at ID Pharma (Japan)?

By fractional works in all years, weighted toward what it does more of than the world: Gene Therapy, Genomic Integration, AAV, Viral Vectors, Vaccine, Epidemiology, Pathogenesis and Immune Response.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Gene Therapy26▲ 69×5 topics
  2. Epidemiology20▲ 3.4×29 topics
  3. Genomic Integration18▲ 122×2 topics
  4. AAV17▲ 182×1 topic
  5. Viral Vectors17▲ 182×1 topic
  6. Vaccine15▲ 26×8 topics
  7. Pathogenesis11▲ 14×9 topics
  8. Immune Response10▲ 12×12 topics
  9. Inflammation8▲ 2.2×25 topics
  10. Transcriptional Regulation6▲ 18×6 topics
  11. Embryonic Stem Cells6▲ 60×2 topics
  12. Differentiation6▲ 54×2 topics
  13. Oxidative Stress6▲ 2.2×21 topics
  14. Pluripotent Stem Cells6▲ 56×2 topics
  15. Gene Silencing5▲ 30×2 topics
  16. Induced Pluripotent Stem Cells5▲ 102×1 topic
  17. Reprogramming5▲ 102×1 topic
  18. Infection5▲ 12×3 topics
  19. Innate Immunity5▲ 9.4×4 topics
  20. Genome Engineering5▲ 55×1 topic
  21. Norovirus5▲ 55×1 topic
  22. RNA Interference5▲ 29×1 topic
  23. RNA-Guided5▲ 55×1 topic
  24. Rotavirus5▲ 55×1 topic
  25. siRNA Delivery5▲ 43×1 topic
  26. Cancer Immunotherapy4▲ 22×3 topics
  27. Immunity4▲ 8.0×7 topics
  28. Immunotherapy4▲ 4.1×6 topics
  29. Viral Pathogenesis4▲ 33×3 topics
  30. Vaccine Development4▲ 7.9×4 topics
  31. Metagenomics3▲ 19×2 topics
  32. Cell Signaling3▲ 6.9×4 topics
  33. Coronavirus3▲ 20×2 topics
  34. Tumor Regression3▲ 26×2 topics
  35. Macular Degeneration3▲ 17×2 topics
  36. Nipah Virus3▲ 85×1 topic
  37. Paramyxovirus3▲ 85×1 topic
  38. Genomic Sequencing3▲ 14×2 topics
  39. Antigen Presentation3▲ 20×2 topics
  40. Circovirus3▲ 54×1 topic

Which research topics does ID Pharma (Japan) publish most on?

By volume in 2022-now: CRISPR and Genetic Engineering, Pluripotent Stem Cells Research, Immune Cell Function and Interaction and Animal Genetics and Reproduction.

CRISPR and Genetic Engin…1CRISPR and Genetic Engineering: 1 fractional worksPluripotent Stem Cells R…0Pluripotent Stem Cells Research: 0 fractional worksImmune Cell Function and…0Immune Cell Function and Interaction: 0 fractional worksAnimal Genetics and Repr…0Animal Genetics and Reproduction: 0 fractional worksT-cell and B-cell Immunology: 0 fractional worksOptical Network Technologies: 0 fractional worksAdvanced Photonic Commun…0Advanced Photonic Communication Systems: 0 fractional worksAdvanced Optical Network…0Advanced Optical Network Technologies: 0 fractional worksAdvanced Chemical Sensor…0Advanced Chemical Sensor Technologies: 0 fractional worksMultidisciplinary Resear…0Multidisciplinary Research Papers Compilation: 0 fractional works
Molecular BiologyImmunologyGeneticsElectrical and Electronic Engineering2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CRISPR and Genetic Engineering Molecular Biology 1 works
  2. 2 Pluripotent Stem Cells Research Molecular Biology 0 works
  3. 3 Immune Cell Function and Interaction Immunology 0 works
  4. 4 Animal Genetics and Reproduction Genetics 0 works
  5. 5 T-cell and B-cell Immunology Immunology 0 works
  6. 6 Optical Network Technologies Electrical and Electronic Engineering 0 works
  7. 7 Advanced Photonic Communication Systems Electrical and Electronic Engineering 0 works
  8. 8 Advanced Optical Network Technologies Electrical and Electronic Engineering 0 works
  9. 9 Advanced Chemical Sensor Technologies Biomedical Engineering 0 works
  10. 10 Multidisciplinary Research Papers Compilation General Social Sciences 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available39.2%not open60.8%

World: 40% of research is openly available.

with international co-authors19.0%domestic only81.0%

World: 18% is written across borders.

How has ID Pharma (Japan)'s research output changed?

Output in 2022-2025 was 23% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is ID Pharma (Japan) as a percentage of every work published that year, 0.000023% in 2024.

still counting0.00025%0.00050%0.00075%ID Pharma (Japan)0.000019% in 20251990200020102020

Fractional works of ID Pharma (Japan) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Tsukuba

All research institutions in Tsukuba

Share ID Pharma (Japan)'s ranking

ID Pharma (Japan) on Science Explorer

A card with ID Pharma (Japan)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about ID Pharma (Japan). Posts are plain text and can be reported.